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a b s t r a c t
Neuraminidase (NA) is a homotetramer viral surface glycoprotein that is essential for virus release during
inﬂuenza virus infections. Previous studies have not explored why inﬂuenza NA forms a tetramer when
the bacterial monomer NA already exhibits excellent NA enzymatic activity levels. In this study, we
focused on 28 highly conserved residues among all NA subtypes, identifying 21 of 28 positions as crucial
residues for viral survival by using reverse genetics. Maintaining NA enzymatic activity levels is critical
and numerous conserved residues were located at the oligomerization interface; however, these
mutations did not affect NA enzymatic activity levels or NA cellular localization, but rather affected
the stability of NA oligomerization, suggesting that the oligomerization of NA is essential for viral
viability. An increased understanding of the biological functions of NA, in particular NA oligomerization,
could facilitate an alternative design for antivirals to combat inﬂuenza virus infections.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Inﬂuenza A viruses are negative-strand enveloped RNA viruses
of the Orthomyxoviridae family that infect a wide range of warm-
blooded animals including domestic and wild birds and mammals
(e.g., humans, pigs, and horses) (Beigel et al., 2005; Chang et al.,
2006; Cox and Subbarao, 2000; Fields et al., 2001). Human viruses
circulate continually in annual epidemics (primarily during the
winter months in temperate climates), and antigenically novel
strains sporadically emerge in the form of pandemic viruses
(Bautista et al., 2010; Cox and Subbarao, 2000; Shih et al., 2005).
The inﬂuenza A virus contains an envelope and 8 viral genome
segments. One of these genes encodes neuraminidase (NA), a
homotetramer and unique enzyme that cleaves α2-3 or α2-6
linked sialic acids of the host cell membrane, facilitating the
release of the newly formed virus, which can subsequently infect
other cells (Nicholls, 2006). Sialic acid is a receptor of the inﬂuenza
virus on host cells (Colman et al., 1983; Palese and Compans, 1976).
The enzymatic and antigenic properties of NA are associated with
the tetrameric globular head that is liberated when the virus is
treated using proteolytic enzymes. The NA tetrameric globular
head can be identiﬁed using electron microscopy, which reveals
surface spikes that resemble long-stalked mushrooms on the
surfaces of the inﬂuenza virus (Fields et al., 2001). NA has been
found to induce enzymatic cleavage in tracheobronchial airway
mucus, subsequently increasing viral penetration to the epithelial
cell layer (Matrosovich et al., 2004). An alternate study showed
that NA can increase viral infectivity by enhancing the endosomal
trafﬁc post-NA entry (Suzuki et al., 2005). Moreover, the NA
derived from WSN strain increases the trypsin-independent clea-
vage of hemagglutinin (HA) by recruiting plasminogen (Goto and
Kawaoka, 1998). In certain N2 strains, NA contains an additional
hemadsorption site that increases its catalytic activity toward
multimeric substrates (Kobasa et al., 1997). NA can also affect
inﬂuenza A virion morphology (Jin et al., 1997; Mitnaul et al., 1996;
Zhang et al., 2000). Previous studies have also shown that the
enzymatic activity of inﬂuenza NA is restored by that of other
bacterial NAs such as Clostridium perfringens and Vibrio cholerae
(Nishikawa et al., 2012).
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Fig. 1. A consensus-based approach for the identiﬁcation of highly conserved amino acid residues in the NA protein. (A) We obtained 2827 NA nucleotide sequences
from GenBank. These included 9 NA subtypes, each containing 714, 1720, 96, 16, 27, 107, 38, 76, and 33 sequences. Consensus sequences were created for each of the
9 subtypes and subsequently aligned with A/WSN/33 NA. (B) A partial view of the 95 highlighted globular amino acid residues from Fig. 1A. The residues of the 28 displayed
positions covered at least 99% of the participating N1 sequences. The WSN-based numbering of these 28 positions appears under the alignment; the N2-based numbering is
included in the parentheses.
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NA proteins mature in several phases. The nascent NA is a
monomer before being transferred to the cytoplasmic membrane.
After the initial interaction of the disulﬁde linkage with cysteine
residues at the transmembrane domain, homodimer formation
proceeds. Subsequently, a continual conformational change at the
globular head and stabilizes the homodimer (Saito et al., 1995).
Each NA monomer comprises six 4-stranded antiparallel β-sheets
that form a propeller-like box-shaped homotetramic arrangement
by way of dimer–dimer interaction (Colman et al., 1993).
Based on various antigenicities, NA can be divided into 10
subtypes (Li et al., 2012; Tong et al., 2012; Zhu et al., 2012). The
most recently identiﬁed NA-like subtype, N10, exhibits low levels
of sequence identity and NA enzymatic activity compared with the
other 9 NA subtypes. These 9 NA subtypes are further divided into
2 groups based on their primary sequences and the structural
properties of the 150-loop at the active site. The NAs differ
structurally by group, displaying no evident genetic relationship
to HA proteins (Russell et al., 2006; Skehel, 2009). Their genomic
sequences differ substantially, with only 52% identicality.
Previous studies have identiﬁed oseltamivir resistance in clin-
ical isolates that were associated with substitutions at residues
119, 198, 274, 292, or 294 in the NA active site (Gubareva et al.,
2002; Mishin et al., 2005; Oxford et al., 2002; Yen et al., 2005). The
mutations that cause drug resistance are located at highly con-
served regions in the NA active site. These mutations compromise
NA enzymatic activity, potentially causing growth disadvantages
for the mutant viruses (Abed et al., 2006; Colman, 2009; Gubareva
et al., 2002; Ison, 2011; Yen et al., 2005). However, drug resistant
viruses have been shown to circulate among humans. According to
an updated World Health Organization report, the former seasonal
inﬂuenza virus A/H1N1 is approximately 100% resistant to oselta-
mivir that targets the NA active site.
To enhance our understanding of NA, we introduced a series of
mutations in the conserved amino acid positions, examining how
they affected viral survival, NA enzymatic activity levels, cellular
localization, and oligomerization ability. The formation of tetra-
mers is unique in the inﬂuenza virus because the bacterial
monomer NA alone is sufﬁcient for NA activity. In this study, we
determined the key amino acid positions for maintaining NA
tetrameric interaction, addressing whether NA oligomerization is
essential for virus viability.
Results
In silico analysis of highly conserved NA residues
By using a consensus-based approach, we identiﬁed 28 highly
conserved residues among 2827 NA amino acid sequences. We
ﬁrst grouped the sequences according to their NA subtypes,
performing multiple sequence alignment on each of the 9 NA
datasets; however, N10 was excluded because of its low levels of
sequence identity and NA enzymatic activity compared with the
other 9 NA subtypes. Subsequently, we generated a consensus
sequence from each NA alignment, aligning the 9 NA consensuses
into the grand NA alignment shown in Fig. 1A (completely
conserved columns shown in black). Because the residues involved
in the formation of the NA tetramer from individual monomers
were our primary interest, we excluded the ﬁrst 6 conserved
residues in the transmembrane domain and targeted 95 conserved
NA globular structure positions.
We used a threshold between 25% and 60% at each aligned
amino acid position to produce a consensus sequence for each of
the 9 NA alignments. Therefore, the identiﬁed 95 NA positions
might not be as completely conserved as displayed in Fig. 1A. To
assess genetic diversity, we expanded the 9-consensus alignment
in Fig. 1A to a full NA alignment containing all 2827 sequences, and
calculated the coverage for each of the consensus residues that
appeared in the 9 subtypes. Fig. 1B shows a partial view of Fig. 1A,
in which the coverage (expressed as a percentage) is indicated
under each residue. For example, the aligned positions 228, 230–
234, 236, and 238 all have fully conserved residues from the N1 to
N9 consensuses. However, for N1, only R at position 230 and T at
position 231 achieved 99% coverage, as shown by R209 and T210
in the WSN coordinate positions in Fig. 1B.
Considering these results, we used the inﬂuenza A WSN virus
(H1N1) in subsequent mutagenesis experiments. We further
screened the 95 positions shown in Fig. 1A according to all the
N1 sequences, ensuring they were conserved for N1 viruses.
By omitting positions exhibiting more than 1% (or 6 N1 sequence
count, inclusive) heterogeneous amino acid residues compared
with the consensus residue, we obtained 28 highly conserved
amino acid residues of NA evolutionary traces that are considered
essential for maintaining NA function. We labeled these at the
bottom of Fig. 1A and B, basing the coordinates on N1 of WSN.
For reference, we also included genomic positions based on the
commonly used N2 numbering in parentheses. Table 1 lists the
detailed amino acid compositions of these 28 positions.
Virus rescue of NA mutations on the conserved amino acid residues
To examine how conserved NA residues affect the generation of
recombinant inﬂuenza viruses, we performed single Ala substitu-
tion experiments in each conserved residue in all 28 predicted
positions. We generated recombinant inﬂuenza viruses by using a
reverse genetics system, employing WT NA or Ala-substituted NAs
in 293T cells. The production of recombinant viruses was detected
by analyzing vRNA expression and virus-induced plaque forma-
tion. In Table 2, the Ala-substituted mutations are divided into
Table 1
The 28 amino acid residues in N1.
Position
at WSN
Position
at N2a
Amino acid
residue
Consensus residues
frequency
Entropy
86 102 K K(603) 0
87 103 D D(562), G(1), 40 gaps 0.25621
104 120 P L(1), P(602) 0.01227
108 124 C C(563), 40 gaps 0.24405
113 129 C C(603) 0
132 148 T T(562), 41 gaps 0.25621
135 151 D D(563), 40 gaps 0.24405
136 152 R R(563), 40 gaps 0.24405
140 156 R G(1), R(561), S(1), 40 gaps 0.26837
142 158 L L(563), 40 gaps 0.24405
181 196 G G(603) 0
192 207 Y Y(603) 0
209 224 R G(1), K(1), R(561), 40 gaps 0.26837
210 225 T A(1), T(562), 40 gaps 0.25621
227 242 T T(603) 0
228 243 D D(603) 0
261 276 E E(603) 0
266 281 Y N(1), Y(602) 0.01227
279 294 N N(601), S(2) 0.02225
286 301 P P(603) 0
332 351 G E(1), G(562), T(40) 0.25621
352 371 R R(590), 13 gaps 0.47477
354 373 G G(545), 53 gaps 0.49958
356 375 E E(540), 63 gaps 0.51619
388 408 G A(1), G(564), 38 gaps 0.43373
413 429 G E(1), G(515), 87 gaps 0.26960
425 442 S S(557), 46 gaps 0.53622
443 460 D D(503), 100 gaps 0.44922
a N2 numbering is according to A/Udorn/72(H3N2) NA sequence (CY009638.1).
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3 categories: (1) mutations that can directly generate recombinant
viruses; (2) mutations that can generate recombinant viruses only
after the addition of exogenous NA (exo-NA); and (3) mutations
that cause viral lethality even with exo-NA.
In Category 1, 7 of the 28 Ala-substituted NA recombinant
viruses (T132A, T210A, D228A, P286A, G332A, E356A, and G388A)
were directly generated using reverse genetics. The Ala-sub-
stituted NA recombinant viruses exhibited plaque formation,
inducing a cytopathic effect in MDCK cells (Fig. 2A and B). This
result indicated that altering conserved residues at the T132, T210,
D228, P286, G332, E356, and G388 positions did not interfere with
virus survival, but interfered with replication and release, parti-
cularly in recombinant viruses D228A, G332A, E356A, and G388A,
which induced small plaque morphologies compared with WT.
In Category 2, 5 Ala-substituted NA recombinant viruses
(P104A, T227A, E261A, N279A, and R352A) were generated using
reverse genetics, adding a functional exo-NA (Fig. 2C and E). This
result suggested that altering the conserved residues of Category
2 recombinant viruses, especially at positions P104, E261, N279,
and R352, affected NA enzymatic activity, subsequently causing
viral lethality. Sixteen of the 28 Ala-substituted NA recombinant
viruses (K86A, D87A, C108A, C113A, D135A, R136A, R140A, L142A,
G181A, Y192A, R209A, Y266A, G354A, G413A, S425A, and D443A)
could not be generated using reverse genetics and induced plaque
morphology, despite the addition of exo-NA (Fig. 2D). This sug-
gested that the conserved residues at the listed positions affect NA
activity (the mutant NA may play a dominant negative effect), or
other functions (e.g., localization and dimerization).
Measurement of Ala-substituted NA enzymatic activity
Our results showed that exo-NA could rescue the mutant
recombinant viruses in Category 2. To conﬁrm whether loss of
NA enzymatic activity causes lethality of the mutants, we
expressed each Ala-substituted NA protein in Category 2 in 293T
cells, measuring NA enzymatic activity by using a MUNANA assay.
The Ala-substituted NA proteins in Category 2 (P104A, T227A,
E261A, N279A, and R352A) displayed 1% to 10% of the NA
enzymatic activity of WT NA (Fig. 3A, upper panel). We used
western blotting to evaluate the protein levels of each of the
Ala-substituted NA proteins in 293T cells (Fig. 3A, lower panel),
determining whether NA substitution affects the NA protein
expression level, which may directly affect NA enzymatic activity
levels. The result showed no obvious decrease for any mutant NA
lysate compared with the WT; by contrast, the expression levels of
P104A, E261A, N279A, and R352A were higher than were those of
the WTs, indicating that the decreased NA enzymatic activity did
not result from the level of expression.
We also examined the NA enzymatic activity levels of those
mutants in Category 3. Fourteen of 16 Ala-substituted NA proteins
showed full NA enzymatic activity levels (Fig. 3B). This concurred
with our previous data (Table 2, Category 3), in which the
functional exo-NA could not replace Ala-substituted NA proteins
to generate those 14 recombinant viruses. Thus, our results
indicate that a lack of NA enzymatic activity is not a key factor
in viral lethality for mutants in Category 3, excepting the K86A and
R140A mutants.
Localization of NA and series mutants in HeLa cells
Matured NA proteins are located at the cytoplasmic mem-
branes, facilitating the release of newly formed viruses (Lai et al.,
2010; Zhang et al., 2000). We examined the localization of
Ala-substituted NA proteins in Category 3 by using confocal
microscopy. The frequencies of cytosol and membrane localiza-
tions were also calculated. We obtained a 2D and 3D view of the
WT NA localization in the HeLa cells. We selected D87A, a variant
that possesses sufﬁcient NA enzymatic activity to represent the
majority of non-rescued recombinant Ala-substituted viruses in
Category 3, identifying its localization (Fig. 4A). We labeled the NA
by using an anti-FLAG Ab and stained it using an immunoﬂuor-
escent dye (488 nm). At 48 h post-transfection, the WT NA was
clearly localized at the cytoplasmic membrane, whereas the D87A
variant was primarily distributed throughout the cytoplasm.
However, this phenomenon was not observed in all the Category
3 variants (Fig. 4B and C). We counted 100 cells to validate the
ﬁnding, counting each variant 3 times. We more frequently
observed the translocation of the WT NA to the cytoplasmic
membrane (47.33% of cases) than that of the Category 3 variants.
The R140A variant was identiﬁed in the cytoplasm in all cases.
The other Category 3 NA variants at the cytoplasmic membrane
were identiﬁed in 16.34% to 38.67% of the cases; approximately
0.18-fold to 0.66-fold (mean, 0.34-fold) less compared with the
WTs. The R140A variant differed substantially from the other
variants; it aggregated, forming several granules in the cytoplasm
(Fig. 4D) rather than localizing at the cytoplasmic membrane.
Our observations suggested that the Ala-substituted NA variants in
Category 3 decreased NAs localization to the cytoplasmic mem-
brane, leading to its accumulation in the cell cytoplasm (e.g., the
R140A variant).
Distribution of highly conserved NA residues
We used the crystal structure of the H5N1 avian inﬂuenza NA
(2HTY) as a template for predicting A/WSN/33 NA to elucidate the
Table 2
Virus rescue of NA mutations on the conserved amino acid residues.
Category Ala-substituted NA
recombinant viruses
C. perfringens
NA
þC. perfringens
NA
vRNA Plaque
forming
vRNA Plaque
forming
Positive
control
Wild type þ þ þ þ
H259Aa   þ þ
1 T132A þ þ þ þ
T210A þ þ þ þ
D228A þ þ þ þ
P286A þ þ þ þ
G332A þ þ þ þ
E356A þ þ þ þ
G388A þ þ þ þ
2 P104A   þ þ
T227A   þ þ
E261A   þ þ
N279A   þ þ
R352A   þ þ
3 K86A    
D87A    
C108A    
C113A    
D135A    
R136A    
R140A    
L142A    
G181A    
Y192A    
R209A    
Y266A    
G354A    
G413A    
S425A    
D443A    
a A point mutation known to reduce NA activity and confer drug resistance
(such as H274Y in N2).
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functions associated with the conserved residues. The 2 NAs
exhibited an 86% amino acid identity. The 28 conserved residues
marked in Fig. 1A are indicated in the ribbon view of the predicted
structure (Fig. 5). We unfolded an NA protein by using 6 β-sheet
domains, observing the conserved residues in each domain
(Fig. 5C). The β6-1 and β6-2 regions coupled, forming a β6 domain,
which is displayed on the right side of Fig. 5B. The majority of the
conserved amino acids were located in the upper half of the
protein, in proximity to the active site; only C108, C113 (both in
β1), Y192 (in β2), and Y266 (in β4) were located at the bottom
(Fig. 5B). We observed at least 2 to 4 highly conserved residues in
each domain that appeared essential for maintaining the structure
and function of NA. The β6-2 and β1 at the N-terminus exhibited
the greatest amount of conserved residues (10 residues). The loop
domain, known to be highly associated with the NA active site
between β3 and β4, also contained 4 conserved residues: T227,
D228, E261, and N279.
To further investigate why the NA mutants that demonstrated
levels of NA enzymatic activity as strong as WTs experienced viral
lethality, we examined the mutation positions on an NA protein.
By referring to the sectional view of an NA simulation structure,
we identiﬁed 7 conserved residues (T132, T210, D228, P286, G332,
E356, and G388) from Category 1 at the inner positions of the NA
monomer (Fig. 5D). We also identiﬁed 5 mutants rescued by exo-
NA in the conserved residues (P104, T227, E261, N279, and R352)
in proximity to the NA enzyme active site (Fig. 5E). The remaining
conserved residues in Category 3 (those mutations caused viral
lethality despite the addition of exo-NA) were primarily located on
the surface of the NA monomer (Fig. 5F). Considering the results
for rescuing Ala-substituted NA viruses and the measured NA
enzymatic activity, we suggest that the conserved residues in the
outer positions of NA monomers (especially on the surface) are
critical for generating live viruses.
Structural modeling of Ala substitution on the NA oligomerization
interface
To investigate the NAs that caused non-rescued recombinant
viruses, we simulated a WSN NA structure in tetramers by using a
GRAMM-X docking server. We labeled the residues adjacent to
other monomers in domains A and B, which contained 45 and 42
amino acid residues, respectively. We identiﬁed the area between
the 2 domains as the oligomerization interface (Fig. 6A). Subse-
quently, we analyzed each of the 28 previously identiﬁed con-
served NA residues, employing a local conformational ﬂuctuation
analysis that accomplished Ala substitution by using the Build
Mutants protocol of the Discovery Studio.
We used Ala substitution at K86 to illustrate the process,
observing 4 distinct conformational changes in domain B com-
pared with the WT (upper-right panel, Fig. 6B). Further analysis
identiﬁed 13 amino acid residues involved in the conformational
changes within a 5-Å radius of K86A (lower-right panel, Fig. 6B).
Fig. 2. Plaque morphology of recombinant Ala-substituted NA viruses. All the recombinant inﬂuenza viruses were generated using reverse genetics. By using a
quantitative plaque assay, viral induced plaques by rescued WT and Category 1 viruses were performed (A and B). Category 2 NA mutated viruses were rescued by adding
exo-NA, producing a smaller plaque morphology compared with that of the WT (C and E). The non-rescued mutants in Category 3 produced no cytopathic effect after viral
ampliﬁcation (D). Panel E indicates the cytopathic effect of infectious MDCK cells in each Category 2 rescued virus at 40 magniﬁcation.
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Fig. 6C displays the molecular dynamics for Ala substitution in
each of the 28 highly conserved NA residues, in which the top
horizontal axis represents the open reading frame of NA, with the β-
strands colored as in Fig. 5C. The second row in Fig. 6C contains the
genomic coordinates, representing the domain A and B residues in
orange and blue, respectively, consistent with Fig. 6A. We marked
positions 95–97 and 153 half in blue and half in orange because of
their location at the juncture of domains A and B, and possible
assignment to either domain. We predominantly observed the dis-
tribution of domain A residues within the 2 structures β1 and β2,
whereas domain B residues were primarily located in β6. Fig. 6D
shows 2 partial views of Fig. 6C in detail. The top panel of Fig. 6D
displays the graphical results of the conformational analysis of a partial
NA sequence, 80–99, in which residue 93 is indicated using an orange
dot, and 8 residues (83–86, 88, 90–92) are indicated using blue dots.
The residues represented by orange or blue dots originated from
domains A and B, respectively, as shown in Fig. 6A. Four Ala-
substituted NA residues are shown in the left column from top to
bottom, resulting in a 420 matrix, with each of its cells indicating
the manner in which a particular Ala-substituted residue might affect
the dynamics of its neighboring residues, especially when the neigh-
boring residues belong to domain A or B. A black square in each of the
seven cells indicates the 7 residues (83 to 89) that K86A affected in
this partial sequence. We used the letter ‘A’ at position 86 to indicate
the location of the Ala substitution. A cell comprising a blue back-
ground indicates an affected residue that belongs to domain B such as
residues 83–86 and 88. In this genomic region, D87A, D443A, and
S425A all heavily affected the domain B residues. The lower panel of
Fig. 6D shows the graphed results of a conformational analysis of
partial NA sequence, 179–198, at the β2 region, in which 13 residues
that belong to domain A are indicated by orange dots. Several cells are
orange, indicating the manner in which Ala substitutions at these
highly conserved NA residues can affect domain A residues. Therefore,
cells that contain black squares and an orange or blue background
represent oligomerization interface residues affected by Ala substitu-
tion. Because numerous such cells were observed for a given residue,
this observation might indicate the importance of this residue in the
formation of a dimer or tetramer from monomers.
All 28 highly conserved NA residues displayed structural
ﬂuctuations in their neighboring residues following Ala substitu-
tion. Fig. 6C shows that the majority of such interactions in
Category 3 residues occurred at the oligomerization interface.
In particular, K86A and D87A from β6-2, and S425A and D443A
from β6-1 heavily affected the domain B residues. Similarly,
D135A, R136A, R140A, and L142A from β1 and G181A and Y192A
from β2 affected the domain B residues. The other Category
3 residues demonstrated a lesser level of interaction with the
oligomerization interface, including C108A, C113A, R209A, Y266A,
and G413A, which affected domain A or B residues. We identiﬁed
the Category 3 residue G354A as irrelevant to the oligomerization
interface, although it affected 21 residues in the β5 region.
Substituting Ala for Category 1 and Category 2 mutant struc-
tures exhibited a major conformational inﬂuence in the β3–β5
regions and loop structures. These mutated structures caused a
reduction in NA activity levels, despite their rescue with or
without the addition of exo-NA (Fig. 3A and Table 2). We also
identiﬁed that T132A, G388A (Category 1), and P104A (Category 2)
inﬂuence the β1 and β6 regions by altering the compactness of the
NA protein (data not shown). However, such alterations did not
result in conformational changes at the oligomerization interface.
Stability of the dimer/tetramer of non-rescued NA mutants
Because several conserved residues critical to virus survival
were located at the oligomerization interface, we performed a
dedimerization assay by using DTT treatment to determine the
Fig. 3. Measurement of Ala-substituted NA enzymatic activity. WT or mutated pFLAG-CMV2-NA plasmids were transfected into 293T cells. Cell lysates were harvested at
48 h post-transfection. The NA enzymatic activity levels of the indicated Ala-substituted NA or WT proteins in Category 2 (A) and Category 3 (B) were measured using a
MUNANA assay. The expression of NA and actin was detected using western blotting. The NA enzymatic activity levels of each transfectant were normalized according to
their levels of NA and actin expression. The NA enzymatic activity levels of the Category 2 mutants were signiﬁcantly different (po0.0001) compared with those of the WT;
panel B shows the variances among the Category 3 mutants and WTs (*, po0.05; ***, po0.0001). Error bars indicates SD, n¼3.
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stability of the Ala-substituted NA proteins in Category 3. All the
Ala-substituted NA proteins were expressed in 293T cells; the
variants and the WTs formed a dimer structure, which was
identiﬁed using native PAGE separation and western blotting
(Fig. 7A). Notably, the Ala-substituted NA proteins of K86 and
R140 formed a strong tetramer, although these mutants showed
signiﬁcantly low NA enzymatic activity levels (Fig. 3B). In the
dedimerization assay, we treated the Ala-substituted NA lysates
using various concentration of DTT, such as 7.81104 μg/μL/
reaction and 3.13103 μg/μL/reaction (1/1280 and 1/320 of 1 μg/
μL/reaction), to identify the residual dimer protein concentrations (%).
Fig. 7B shows a WT NA protein dissociated from a dimer to a
monomer after serial dilution of the DTT treatment. Fig. 7C shows
that the WT NA retained 70.61% and 27.35% of the dimer proteins
following the 1/1280 DTT and 1/320 DTT treatments, respectively.
We also selected a mutant from Category 1 (T132A) for comparison.
This mutant retained 71.48% and 45.32% of the dimer proteins
following the 1/1280 DTT and 1/320 DTT treatments, respectively.
According to our previous structural modeling results, G354A had no
direct inﬂuence on domain A or B residues (Fig. 6C); this variant
displayed minimal dedimerization following DTT treatment.
We identiﬁed four Ala-substituted NA proteins (K86A, R140A,
G354A, and D443A) as lethal mutants in Category 3, which
displayed a lower dedimerization rate than did the WT following
the 1/1280 DTT and 1/320 DTT treatments (Fig. 7C). Other
Category 3 variants were more unstable than were the WT,
exhibiting an average 0.38-fold and 0.65-fold reduction in the
residual dimer proteins after the 1/1280 DTT and 1/320 DTT
treatments, respectively. The Ala-substituted NA proteins that
inﬂuenced the oligomerization interface at domain A (D135A,
R136A, R140A, L142A, G181A, Y192A, and R209A) showed strong
dedimerization rates and an average 0.37-fold reduction in dimer
proteins (po0.05). Following the 1/1280 DDT treatment, the
residual dimer proteins of the L142A variant reduced 0.67-fold.
After subsequent 1/320 DDT treatments, these 7 mutants exhib-
ited a signiﬁcant dedimerization rate, demonstrating an average
0.65-fold reduction in the dimer proteins (po0.0005), particu-
larly, the dimer proteins of the R136A variant reduced 0.88-fold.
Following both treatments, the Ala-substituted NA proteins that
inﬂuenced the oligomerization interface at domain B (K86A, D87A,
C108A, C113A, Y266A, G413A, S425A, and D443A) showed 0.23-
fold and 0.14-fold reductions in the dimer proteins. The K86A
variant exhibited a strong dimerization structure, demonstrating
increased stability following the 1/1280 and 1/320 DTT treatments
and showing 0.39-fold and 2.20-fold dimer protein increases. After
excluding the K86A variant from the subgroup (domain B), we
observed 0.32-fold and 0.48-fold reductions in the residual dimer
proteins following both treatments (po0.05). Another stable
R140A variant showed a level of dimer dissociation similar to that
of the WT following the 1/1280 DTT treatment, but it rapidly
Fig. 4. Localization of WT NA and non-rescued mutants in HeLa cells. A confocal imaging system was used to identify the localization of Ala-substituted NA, which
expressed in HeLa cells at 48 h post-transfection. (A) The localization of the WT NA and D87A mutant is shown in the 2D and 3D images, in which D87A is the most common
of the Category 3 mutants. NAs at the plasma membrane or in the cytoplasm were detected using an anti-FLAG Ab and an anti-mouse immunoﬂuorescence dye (488 nm,
green). The plasma membrane and nucleus were stained using Dil (594 nm, red) and Hoechst (350 nm, blue), respectively. The image magniﬁcation was 630 . (B) The
distribution of all Category 3 Ala-substituted NA proteins in HeLa cells was identiﬁed using a confocal microscope at 1000 magniﬁcation. (C) The ratio of NA mutants that
occurred at the plasma membrane or in the cytoplasm was evaluated by counting 100 cells/mutant 3 times and presenting the results as percentages, comprising a standard
error bar. The distribution of NA mutants at cytoplasmic membrane showed signiﬁcantly different ratio (po0.01) and the signiﬁcant differences to WT were indicated
(*, po0.05; **, po0.01; ***, po0.001) (D) A mutant, R140A, was selected to show separate ﬂuorescence signal layers (FLAG-NA in green, Dil in red, and nuclei in blue) at
1000 magniﬁcation.
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dissociated following the 1/320 DTT treatment and the proportion
of the residual dimer proteins decreased from 72.29% to 13.86%,
resulting in a 0.49-fold reduction (Fig. 7C).
The results suggest that Ala substitution at the NA oligomeriza-
tion interface disrupts the stability of the NA dimer/tetramer,
thereby limiting the generation of recombinant Ala-substituted
NA viruses.
Discussion
In this study, we used a set of NA sequences collected prior to
2007 to identify 28 highly conserved NA amino acid residues.
We subsequently validated our results using an updated data set,
which was assembled in 2011 (data not shown). We observed 95
conserved regions and 28 highly conserved amino acid residues in
the NA globular structure, which accounted for 20.17% and 5.94%
of the entire NA protein structure, respectively (Figs. 1A and 5).
To summarize, we identiﬁed that 21 of the 28 (75%, including
Category 2 and 3) highly conserved residues in NA are essential for
the survival of the inﬂuenza A virus; however, deﬁcient NA enzymatic
activity levels or an unstable NA dimer/tetramer might limit the
generation of infectious viruses. In Category 3, 13 of the 16 non-
rescued mutant viruses (excluding K86A, G354A, and D443A) con-
tained a higher proportion of unstable homodimer proteins than
did the WT or rescued variants (T132A). This result indicated that
the evolutionary conserved residues at the oligomerization interface
play a crucial role in maintaining useable NA homotetramers. In
addition, the K86A mutant protein exhibited a stable dimer structure
after DTT treatment; this substituted at position 86 might alter the
NA conformation, forming a DTT-resistant structure. However, DTT-
resistant structures will inhibit the reduction of dedimerization by DTT
treatment (Tatu et al., 1993).
Fig. 5. Simulation of the NA structure of A/WSN/33 using a SWISS modeling server, with the positions of 28 highly conserved residues labeled. An NA monomer was
formed using 6 β-sheet domains, with the conserved amino residues distributed among each of these domains. (A) Top view, (B) side view, (C) open frame according to each
β-sheet (reference: 2HTY, N1 NA, 86% amino acid identity). Alanine substitution in the 28 highly conserved residue positions generated a series of recombinant NA mutant
viruses. Panels D, E, and F show the distributions of these residues. We categorized (D) 7 recombinant viruses rescued using reverse genetics in Category 1, (E) 5 that lacked
NA enzymatic activity in Category 2, and (F) 16 that were not rescued in Category 3, despite using exo-NA to replace the viral NA enzymatic function.
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The in silico simulation results, which were obtained using the
GRAMM-X docking server and Discovery Studio, indicated the
reason for the lack of mutated virus rescue in the Category
3 residues. Fig. 6C shows that Ala substitution speciﬁc to one of
the conserved NA sites changed the structure at that location,
inducing confounding effects on other locations. Therefore, a
microcosmic change within a single amino acid can substantially
alter the molecular dynamics in the NA homotetramer. We
identiﬁed that numerous NA positions are involved in the forma-
tion of a dimer or tetramer complex from monomers (Fig. 8). In
particular, the G181 and Y192 at domain A, and K86, D87, and C113
at domain B might be responsible for forming the dimer structure
through hydrogen bonding. The mutated positions at D135, R136,
R140, L142, R209, and C108, S425, D443 were affected at other
locations in both domains. These might represent the key residues
involved in forming the ordered box-shaped arrangement of the
NA tetramer. Maintaining molecular stability by conserving these
residues might be a crucial stage in the virus life cycle.
According to our NA localization observations, an elastic NA
homotetramer structure might not be essential for NA transloca-
tion from cytoplasmic organelles to membranes, and may be
irrelevant to full NA enzymatic activity (Figs. 3B and 4B and C).
In addition to reducing the levels of NA enzymatic activity and
accumulation in cytoplasm, the mutated position at R140, R140K
may reduce its NA inhibitor binding by reducing the level of NA
activity and compromising the replication of normal human
bronchial epithelial cells (Ilyushina et al., 2012). However, our
results suggested that a functional NA protein can assemble and
bud without the participation of other viral proteins (Lai et al.,
2010); this was further evidenced by the NA-overexpressing HeLa
cells that demonstrated multiple spines or pseudopodium on the
cell surface (Fig. 4).
In the previous century, 2 common NA inhibitors (oseltamivir
and zanamivir) were crucial for controlling inﬂuenza virus infec-
tions. Considering the continual reports of NA inhibitor-resistant
cases, monitoring drug-resistant markers should help prevent the
emergence of additional drug-resistant viruses (Bloom et al., 2010,
2011). Our results indicated that 7 positions (K86, P104, R140,
T227, E261, N279, and R352) are critically involved in maintaining
NA enzymatic activity levels, and these levels reduced following
Ala substitution (Fig. 3). Among the positions, E261(E276 in N2),
N279(N294), and R352(R371) are signature mutations associated
Fig. 6. Effects of alanine substitution on the oligomerization interface according to computational analysis. The amino acid residues that interacted with other
monomers were categorized into domains A (orange) and B (blue) by using the GRAMM-X Protein Docking Server (panel A). The Ala substitution of K86 (a domain B residue)
caused conformational changes at oligomerization interface compared with the WT; the affected residues are labeled in blue (panel B). Panel C displays the protein structure
of NA, in which domains A and B are represented by orange and blue, respectively, illustrating how the 28 highly conserved residues interacted with the NA structure and
indicating the inﬂuence of Ala substitution in the 3 listed categories. A black square (■) indicates a dynamically changed residue, whereas the letter “A” indicates its Ala
substitution site. Such affected residues were shown in orange or blue if they belonged to domains A or B, respectively. In summary, the lethally mutated Ala-substituted
viruses in Category 3 are associated with homotetramer oligomerization. However, interference rarely occurred as a result of the positions in Categories 1 and 2.
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with antiviral drug resistance. Previous studies have identiﬁed
mutations of E261D(E276D) and R352K(R371K) in the H3N2 virus
subtype, and N279S(N294S) in H1N1 (Abed et al., 2006; Colman,
2009; Ison, 2011). Our results showed that the exo-NA from
bacteria rescued E261A, N279A, and E352A. Therefore, the infec-
tion of a patient with these drug-resistant viruses might increase
the treatment burden, especially regarding opportunistic infec-
tions by microbes that exhibit similar virulence factors to NA
(Nishikawa et al., 2012).
We characterized 3 positions in Category 3 (D135, R136, and
R209) that suggest resistance in H3N2, D135E(D151E) and R209K
(R224K), and in the inﬂuenza B virus, R136A(R152K) (Colman,
2009; Ison, 2011). Although substituting Ala might signiﬁcantly
affect protein structures, our results indicated 6 positions (D135,
R136, R209, E261, N279, and E352) as potential drug-resistance
markers, which has been reported previously that the alteration of
residues among same property. Previous studies have not reported
P104 and T227 as markers of resistance to NA inhibitors. Therefore,
these 2 positions could represent reference targets for modifying
anti-NA activity drug designs.
From the computational predictions to the functional validation,
the results of this study have increased our understanding of NA
function and homotetramer oligomerization, suggesting that the
ordered arrangement of NA is critical in the generation of an infectious
inﬂuenza virus. These ﬁndings could lead to the design of a novel
antiviral drug to protect against inﬂuenza virus infections.
Materials and methods
Sequence analysis and protein structure modeling
All NA sequences were collected from GenBank. Multiple
sequence alignment was conducted using ClustalW version 1.83
(Hall, 1999) and the aligned sequences were generated using
GeneDoc version 2.6.002 (Nicholas et al., 1997). The protein
structures of A/WSN/33 NA wild type (WT) and mutants were
simulated and analyzed using the Swiss-Model program (Schwede
et al., 2003), based on the reference structure 2HTY, which was
obtained from the RCSB Protein Data Bank (Berman et al., 2000).
The protein structures were presented using the user-sponsored
molecular visualization system PyMOL, version 0.99 (Schrodinger,
2010). The amino acids were numbered based on
A/WSN/33, employing N2 numbering (accession no. CY009638.1)
in the parentheses.
Fig. 7. Stability of the oligomerization of non-rescued NA mutants. WT or mutated pFLAG-CMV2-NA plasmid-transfected 293T cells were lysed and harvested at 48 h
post-transfection. (A) The Category 3 Ala-substituted NA lysates were analyzed using 4% to 12% native PAGE and the tetramer/dimer NAwere detected using western blotting
and an anti-FLAG Ab. (B) To challenge the stability of the NA dimer, a serial concentration of DTT was used to treat the NA lysates. The dedimerization level of the WT NAwas
analyzed using 8% native PAGE and demonstrated using western blotting and an anti-FLAG Ab. To serve as an internal control, actin was detected using western blotting and
an 8% SDS-PAGE analysis. (C) Using the same approach as that in panel B, the Category 3 Ala-substituted NA lysates were treated using diluted 1/1280 DTT or 1/320 DTT. The
residual dimers were quantiﬁed and compared to each untreated (mock) sample, and the results were presented as percentages. The dotted lines show the dedimerization
levels of WT NA following 1/1280 DTT or 1/320 DTT treatment. The solid line shows the dedimerization average of each sub-group of Ala-substituted NA. In addition to the
WT NA, T132A from Category 1 was selected to represent a well-generated Ala-substituted NA inﬂuenza virus. Error bars indicates SD, n¼3. (*, po0.05; ***, po0.0005).
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Cell lines
Madin-Darby canine kidney (MDCK) cells, human embryonic
kidney 293 T cells, and HeLa cells were maintained in a Dulbecco's
minimal essential medium (DMEM) supplemented using a 10%
fetal bovine serum (Gibco), 1% nonessential amino acids (Gibco),
and a 1x antibiotic–antimycotic (Gibco). The cells were maintained
at 37 1C by using 5% CO2.
Generation of recombinant viruses and plaque assay
The indicated recombinant viruses were generated using a
12-plasmid-based reverse genetics system (Chiang et al., 2008;
Fodor et al., 1999). The expression plasmids of each A/WSN/33
segment were kindly provided by Dr George G. Brownlee from the
University of Oxford, UK. The culture medium was collected at
96 h post-transfection and added to MDCK cells, infecting them
with the virus; this infection procedure was repeated 3 times.
Regarding NA reconstitution assays, 2 mU/mL of C. perfringens NA
(Sigma) was added to the medium. The generation of recombinant
viruses was conﬁrmed by detecting RNA and assessing plaque
formation.
Site-directed mutagenesis of NA mutants
Alanine (Ala) substitution constructs were introduced to the
pPOLI-NA-RT plasmid by using the aforementioned site-directed
mutagenesis method (Chiang et al., 2008). The constructs were
sequenced to ensure that speciﬁcally introduced mutations were
present in the plasmids.
RNA extraction and reverse transcription-polymerase chain reaction
(RT-PCR)
Viral RNA (vRNA) was harvested from the infected MDCK cells
by using a Viral RNA Extraction kit (Viogene, Taiwan) according to
the manufacturer's instructions. The cDNA was generated using a
ReverTra Ace kit (TOYOBO) with a primer complementary to the 12
conversed base pairs at the 3′-end of the NA vRNA segment, as
described (Hoffmann et al., 2001). The NA gene was then ampliﬁed
using a KOD-Plus kit (TOYOBO) according to the manufacturer's
protocol.
Plaque assay in MDCK cells
Conﬂuent MDCK cells were placed in 6-well plates, rinsed
using phosphate-buffered saline (PBS), and subsequently adsorbed
the diluted viruses for 1 h at 37 1C. The mediumwas discarded and
the cells were rinsed using PBS. The cells were overlaid with 2 mL
of DMEM supplemented by 0.3% agar and 1 μL/mL of 0.25% (w/v)
trypsin (Gibco). In addition, 2 mU/mL of C. perfringens NA (Sigma)
was added to the overlaid agar medium to rescue the NA activity,
which was deﬁcient as a result of the mutant virus. After incuba-
tion at 37 1C for 3d, the plaques were ﬁxed using 10% formalin for
1 h and stained using a 0.1% crystal violet solution.
Preparation of FLAG-fused NA protein and western blotting
The indicated NA mutants were ampliﬁed from pPOLI-NA-RT
plasmids by using PCR and a KOD-Plus kit (TOYOBO) that com-
prised a sense primer 5′-CGGAATTCCatgaatccaaaccagaaaataataacc-
3′ and antisense primer 5′-CCCCATGGGGctacttgtcaatggtgaacgg-
caa-3′. Each NA mutant sequence was inserted into a pFLAG-
CMV2 expression vector (Sigma) at EcoRI and KpnI sites. Three
micrograms of the indicated pFLAG-CMV2-NA plasmids were
transfected into 293 T cells by using Lipofectamine 2000 (Invitro-
gen) according to the manufacturer's instructions. At 48 h post-
transfection, each 293 T transfectant was lysed in lysis buffer (1%
CA-630, 150 mM NaCl, 50 mM Tris-base, pH 8.0) at 4 1C overnight,
and the cell lysates were subsequently collected. Fifty micrograms
of the cell lysates were resolved using electrophoresis in an SDS-
polyacrylamide gel and transferred to a polyvinylidene diﬂuoride
membrane (GE Healthcare). Antibodies against FLAG (diluted
1:2000; Sigma) and actin (diluted 1:2000; Merck Millipore) were
used. After washing, the membrane was incubated using a horse-
radish peroxidase(HRP)-conjugated anti-mouse antibody (Ab,
diluted 1:2000; GE Healthcare). The HRP was detected using a
Western Lightning Chemiluminescence kit (GE Healthcare) and
exposed to chemiluminescence ﬁlm (Kodak).
Analysis of NA enzymatic activity
A modiﬁed ﬂuorometric assay was used to identify the NA
enzymatic activity of the FLAG-NA proteins expressed by 293T
cells (Hung et al., 2009; Potier et al., 1979). Fifty micrograms of the
cell lysates were evaluated. This assay was performed in 32.5 μM
morpholineethanesulfonic acid (Sigma) at pH 6.5 and 4 mM CaCl2,
using a ﬂuorogenic substrate 2′-(4-methylumbelliferyl)-α-D-N-
acetylneuraminic acid (MUNANA; Toronto Research Chemicals
Fig. 8. Key amino acid residues bear the NA dimer/tetramer structure. The
domain A and B residues that interacted with other monomers are labeled in
orange and blue. Category 3 conserved residues are indicated by individual colors
in the sectional top (upper panel) and side views (lower panel) of the dimer
structures. We numbered key amino acid residues that showed the NA dimer/
tetramer structure according to the WSN positions.
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Inc., Canada) at a concentration of 100 mM. The reaction mixture
was incubated at 37 1C for 1 h and the reaction was halted by
adding 150 mL of stop solution (0.1 M glycine in 25% ethanol, pH
10.7). The ﬂuorescence of the released 4-methylumbelliferone was
measured using a spectrophotometer at excitation and emission
wavelengths of 360 nm and 460 nm, respectively. The values for
the NA enzymatic activity were normalized to NA expression by
using a Multi Gauge v3.0 (FujiFilm), and presented as a percentage
compared with the WT. Each experiment was independently
performed 3 times.
Confocal microscopy
HeLa cells (105) were plated 1 d prior to transfection in 22-mm
petri dishes. At 24 h post-transfection by 1 μg pFLAG-CMV2-NA
using XtremeGENE 9 (Roche) according to the manufacturer's
protocol, the cells were reseeded on 20-mm coverslips to obtain
30% to 40% conﬂuent monolayers. At 48 h post-transfection, the
cells were prestained using Dil (Invitrogen) according to the
manufacturer's instructions, then ﬁxed in 4% paraformaldehyde
for 20 min. The permeabilization was performed in 0.3% Triton
X-100 for 15 min. The cells were stained using an anti-FLAG Ab
(diluted 1:1000; Sigma) and a ﬂuorescein isothiocyanate (FITC)-
conjugated anti-mouse secondary Ab (diluted 1:800; Invitrogen)
to detect FLAG-NA. Hoechst 33258 (Invitrogen) and Dil stains were
used to detect the nucleus and membrane lipids, respectively. All
images were captured using inverted confocal microscopy (LSM
510 Meta, Zeiss) and processed using LSM 510 software. Ten to 20
optimal sections along the z-axis were acquired in 0.5-mm incre-
ments for 3D imaging. The central sections of the captured images
are displayed.
Computational analysis of protein structure dynamics
The dynamic interaction between 2 NA monomers was inves-
tigated using a series of docking models, and determined using the
Global RAnge Molecular Matching (GRAMM) methodology based
on the crystallographic structure of N1 (2HTY). The GRAMM-X
public web server (Tovchigrechko and Vakser, 2005, 2006) was
used to determine the docking pairs of protein molecules, in which
the potential energy was minimized and the root mean square
deviations (RMSDs) of the 2 structures were calculated until
reaching less than 0.5.
The molecular structures of mutants were built using the Build
Mutants protocol of the Accelrys Discovery Studio 2.0 (DS),
employing a high level of optimization and 5-Å radius cutting
parameters (Shih et al., 2011). The conserved NA residues were
Ala-substituted, and each of the mutant proteins was energy-
minimized using the molecular dynamic simulation package in DS
by employing a CHARMm force ﬁeld at the default settings. The
amino acid residues showed conformation changes after the Ala
substitutions were graphed.
Stability of NA dimer/tetramers
To determine the stability of NA dimer/tetramers, dithiothreitol
(DTT; Sigma) was used to reduce the disulﬁde bond of the NA
protein (Awasthi et al., 2012; Gotte and Libonati, 2008). A series
diluted DTTs was incubated with 50 μg of FLAG-NA cell lysates at
37 1C for 5 min, then further separated using native gradient PAGE.
The concentrations of the residual dimer proteins were deter-
mined using western blotting and an anti-FLAG Ab (diluted
1:2000; Sigma), and analyzed using Multi Gauge v3.0 (FujiFilm);
the results were expressed as a percentage compared with the
untreated samples.
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